Skip to content
★ Sign in to follow
TM

Thomas M. Ross

Vice-Président Exécutif
Total declarations
57
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (27 ops.)
€2.9M

Latest filing published 05 Aug 2024 for Maxcyte, INC., €24k.

Insider track record

Disclosed buys
0
Disclosed sells
27

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Thomas M. Ross: trading record in brief

Thomas M. Ross is a declared insider of Maxcyte, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 12 November 2021 and 2 August 2024, the trades on record add up to 57 filings.

Every open-market trade on record is a sale: 27 sales worth €2.9M. Outside the open market, there are 1 share grant and 29 option exercises. In 2024 alone, the filings show no purchases and 5 sales.

The newest entry dates from 5 August 2024: an option exercise of €27k, in Maxcyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Thomas M. Ross

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • ◇
    EVP, GLOBAL SALESExecutivesMaxcyte, Inc.
    25,396 USD12SEC
    15,476 shares@ US$1.6419.2% of flowCommon StockSEC:0001415889-24-020785:0
  • ◇
    EVP, GLOBAL SALESExecutivesMaxcyte, Inc.
    32,495 USD12SEC
    19,802 shares@ US$1.64111.8% of flowCommon StockSEC:0001415889-24-019463:0
  • ◇
    EVP, GLOBAL SALESExecutivesMaxcyte, Inc.
    54,699 USD13SEC
    33,333 shares@ US$1.64120.0% of flowCommon StockSEC:0001415889-24-017956:0
  • ◆
    EVP, GLOBAL SALES & MARKETINGExecutivesMaxcyte, Inc.
    0SEC
    25,000 shares0Common StockSEC:0001415889-24-008640:0
  • ◇
    EVP, Global Sales & MarketingExecutivesMaxcyte, Inc.
    214 USD11SEC
    100 shares@ US$2.1420.1% of flowCommon StockSEC:0001209191-23-024116:0
  • ◇
    EVP, Global Sales & MarketingExecutivesMaxcyte, Inc.
    14,923 USD12SEC
    6,967 shares@ US$2.1425.4% of flowCommon StockSEC:0001209191-23-023809:0
  • ◇
    EVP, Global Sales & MarketingExecutivesMaxcyte, Inc.
    5,584 USD11SEC
    2,607 shares@ US$2.1422.0% of flowCommon StockSEC:0001209191-23-022988:0
  • ◇
    EVP, Global Sales & MarketingExecutivesMaxcyte, Inc.
    2,426 USD11SEC
    2,468 shares@ US$0.9830.9% of flowCommon StockSEC:0001209191-23-006880:0
  • ◇
    EVP, Global Sales & MarketingExecutivesMaxcyte, Inc.
    10,334 USD11SEC
    10,513 shares@ US$0.9833.8% of flowCommon StockSEC:0001209191-23-001980:0
  • ◇
    EVP, Global Sales & MarketingExecutivesMaxcyte, Inc.
    16,200 USD12SEC
    15,000 shares@ US$1.086.0% of flowCommon StockSEC:0001209191-22-060077:0
  • ◇
    EVP, Global Sales & MarketingExecutivesMaxcyte, Inc.
    19,680 USD12SEC
    23,429 shares@ US$0.847.8% of flowCommon StockSEC:0001209191-22-055528:0
  • ◇
    EVP, Global Sales & MarketingExecutivesMaxcyte, Inc.
    20,875 USD12SEC
    24,851 shares@ US$0.848.4% of flowCommon StockSEC:0001209191-22-053456:0
  • ◇
    EVP, Global SalesExecutivesMaxcyte, Inc.
    35,776 USD12SEC
    42,590 shares@ US$0.8414.0% of flowCommon StockSEC:0001209191-21-064881:0

13 of 13 declarations